David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Bioethical Inquiry 2 (2):69-74 (2005)
New Zealand is one of two OECD countries in the world where direct-to-consumer advertising of prescription medicine (DTCA-PM) is permitted. Increase in such activity in recent years has resulted in a disproportionate increase in dispensary volume of heavily advertised medicines. Concern for the potential harm to healthcare consumers and the public healthcare system has prompted the medical profession to call for a ban on DTCA-PM as the best way of protecting the public interest. Such blanket prohibition however also interferes with the public’s right of access to information. This paper will examine if banning DTCA-PM would constitute a justified form of paternalism in the context of today’s New Zealand.
|Keywords||Drug industry advertising public policy ethics|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
Dr Annette Braunack-Mayer, Sandy Elkin, Pauline Norris & Dr Hamish J. Wilson (2005). Ethics and Law for the Health Professions. Journal of Bioethical Inquiry 2 (3):177-182.
Similar books and articles
Daniel Attas (1999). What's Wrong with "Deceptive" Advertising? Journal of Business Ethics 21 (1):49 - 59.
Pepijn K. C. van de Pol & Frank G. A. de Bakker (2010). Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility? Journal of Business Ethics 94 (2):211-224.
Richard F. Beltramini (2006). Consumer Believability of Information in Direct-to-Consumer (DTC) Advertising of Prescription Drugs. Journal of Business Ethics 63 (4):333 - 343.
Christopher Jordens & Lynley Anderson (2005). Should We Be Concerned About Direct-to-Consumer Advertising of Prescription Drugs? Journal of Bioethical Inquiry 2 (2):61-62.
R. Stephen Parker & Charles E. Pettijohn (2003). Ethical Considerations in the Use of Direct-to-Consumer Advertising and Pharmaceutical Promotions: The Impact on Pharmaceutical Sales and Physicians. [REVIEW] Journal of Business Ethics 48 (3):279-290.
Rosa Lynn B. Pinkus (2002). From Lydia Pinkham to Bob Dole: What the Changing Face of Direct-to-Consumer Drug Advertising Reveals About the Professionalism of Medicine. Kennedy Institute of Ethics Journal 12 (2):141-158.
Ashish Chandra & Gary A. Holt (1999). Pharmaceutical Advertisements: How They Deceive Patients. [REVIEW] Journal of Business Ethics 18 (4):359 - 366.
Andreas Hasman & Søren Holm (2005). Direct-to-Consumer Advertising: Should There Be a Free Market in Healthcare Information? Cambridge Quarterly of Healthcare Ethics 15 (01):42-49.
Thaddeus Mason Pope, Is Public Health Paternalism Really Never Justified? A Response to Joel Feinberg.
Betty B. Chaar & Johnson Lee (2012). Role of Socioeconomic Status on Consumers' Attitudes Towards DTCA of Prescription Medicines in Australia. Journal of Business Ethics 105 (4):447-460.
Added to index2009-01-28
Total downloads32 ( #58,366 of 1,101,884 )
Recent downloads (6 months)7 ( #41,658 of 1,101,884 )
How can I increase my downloads?